ADMA Biologics Inc Logo

ADMA Biologics Inc (ADMA): Eigentümerstruktur

Takani Score ?
75.4

Preis (11.09.2026)52W Hoch52W Tief
9,23 US Dollar20,458 US Dollar7,21 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
17 US Dollar20100
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
223.984.68013,1310,58

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name ADMA Biologics Inc
Mitarbeiter 640
Handelsplatz NASDAQ
Ticker Symbol ADMA
IPO Datum 2013-10-17
Adresse 465 State Route 17, Ramsey, NJ, United States, 07446

Unternehmensführung

RangNamePosition
1Mr. Adam S. GrossmanCo-Founder, President, CEO & Director
2Dr. Jerrold B. Grossman D.P.S., Ph.D.Co-Founder & Vice Chairman of the Board
3Mr. P. Terence KohlerCFO & Treasurer
4Ms. Kaitlin M. KestenbergCOO & Senior VP of Compliance
5Mr. Michael GoldsteinGeneral Counsel
6Mr. John HaflExecutive Director of Sales
7Mr. Skyler BloomSenior Director of Business Development & Corporate Strategy

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1BlackRock Inc16,44%0,34 Mrd. USD
2State Street Corp6,29%0,13 Mrd. USD
3Vanguard Capital Management, LLC4,60%0,10 Mrd. USD
4Vanguard Portfolio Management, LLC3,96%0,08 Mrd. USD
5Capital Research Global Investors3,91%0,08 Mrd. USD
6First Trust Advisors L.P.3,48%0,07 Mrd. USD
7Nuveen, LLC2,72%0,06 Mrd. USD
8Geode Capital Management, LLC2,60%0,05 Mrd. USD
9Caligan Partners LP2,56%0,05 Mrd. USD
10D. E. Shaw & Co LP2,35%0,05 Mrd. USD
11Amvescap Plc.1,84%0,04 Mrd. USD
12Bank of America Corp1,78%0,04 Mrd. USD
13Dimensional Fund Advisors, Inc.1,61%0,03 Mrd. USD
14Point72 Asset Management, L.P.1,47%0,03 Mrd. USD
15B Group, Inc1,43%0,03 Mrd. USD
16Jane Street Group LLC1,36%0,03 Mrd. USD
17The Goldman Sachs Group Inc1,25%0,03 Mrd. USD
18Morgan Stanley - Brokerage Accounts1,09%0,02 Mrd. USD
19Franklin Templeton Inc1,05%0,02 Mrd. USD
20Northern Trust Corp1,02%0,02 Mrd. USD